Package 71205-465-30

{"route": ["ORAL"], "spl_id": "293ee809-1b3d-4f31-9d46-ac413f126906", "openfda": {"upc": ["0371205465308"], "unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["5d40e301-7e06-4ecd-b7c6-3d7ac6a134d2"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-30)", "package_ndc": "71205-465-30", "marketing_start_date": "20200729"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-60)", "package_ndc": "71205-465-60", "marketing_start_date": "20200729"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-465-90)", "package_ndc": "71205-465-90", "marketing_start_date": "20200729"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "71205-465_293ee809-1b3d-4f31-9d46-ac413f126906", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71205-465", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20190325", "listing_expiration_date": "20261231"}